Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 991-995

  Han, Ki Ok ^a   Moon, In Gul ^a   Kang, Young Soon ^a   Chung, Ho Yeon ^a   Min, Hun Ki ^a   Han, In Kwon ^a  

^a Samsung Advanced Institute of Technology (SAIT)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DNA; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CHROMOSOME 6Q; ESTROGEN THERAPY; FEMALE; GENE LOCUS; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; KOREA; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0343766475     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.4.3879     Document Type: Article

References (25)

1. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med. 331:1056-1061.
2. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. 1996 Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res. 11:306-311.
3. Qi JC, Morrison NA, Nguyen TV, et al. 1995 Estrogen receptor genotypes and bone mineral density in women and men. J Bone Miner Res. 10:S170.
4. Hassager C, Jensen SB, Christiansen C. 1994 Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist? Osteoporosis Int. 4:36-41.
5. Garcia T, Lehrer S, Bloomer WD, Schachter B. 1988 A variant estrogen receptor messenger ribonucleic acid is associated with reduced level of estrogen binding in human mammary tumors. Mol Endocrinol. 2:785-791.
6. Yaich L, Dupont WD, Cavener DR, Parl FE. 1992 Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res. 52:77-83.
7. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Borresen A-L. 1994 Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet. 94:665-670.
8. Kim SW, Lim CH, Han KO, Jung HY, Min HK, Han IK. Standardization of dual energy X-ray absorptiometry (DXA) in spinal BMD of Korean women and phantom. Proc of the 10th Int Congr of Endocrinol. 1996; 372.
9. Ponglikitmongkol M, Green S, Chambon P. 1988 Genomic organization of the human oestrogen receptor gene. EMBO J. 7:3385-3388.
10. Macri P, Khoriaty G, Lehrer S, Karurunaratne A, Milne C, Schachter BS. 1992 Corrigendum: sequence of a human estrogen receptor variant allele. Nucleic Acids Res. 20:2008.
11. Lehrer S, Sanchez M, Song HK, et al. 1990 Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet. 335:622-624.
12. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. 1987 Genetic determinants of bone mass in adults. A twin study. J Clin Invest. 80:706-710.
13. Dequeker J, Nijs J, Verstraeten A, Geusens P, Gevers G. 1987 Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone. 8:207-209.
14. Kelly PJ, Eisman JA, Sambrook PN. 1990 Interaction of genetic and environmental influences on peak bone density. Osteoporosis Int. 1:56-60.
15. Krall EA, Dawson-Hughes B. 1993 Heritable and lifestyle determinants of bone mineral density. J Bone Miner Res. 8:1-9.
16. Morrison NA, Qi JC, Tokita A, et al. 1994 Prediction of bone density from vitamin D receptor alleles. Nature. 367:284-287.
17. Peacock M. 1995 Vitamin D receptor alleles and osteoporosis: a contrasting view. J Bone Miner Res. 10:1294-1297.
18. Genant HK, Cann CE, Ettinger B, Gordan GS. 1982 Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophrectomy. Arch Intern Med. 97:699-705.
19. Riis BJ, Thomsen K, Strom V, Christiansen C. 1987 The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol. 156:61-65.
20. Hodgkinson A, Thompson T. 1982 Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex. J Clin Pathol. 35:807-11.
21. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI. 1990 Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet. 336:265-269.
22. Harmon JM, Elsasser MS, Eisen LP, Urda LA, Ashraf J, Thompson EB. 1989 Glucocorticoid receptor expression in receptorless mutants isolated from the human leukemic cell line CEM-C7. Mol Endocrinol. 3:734-743.
23. Brown TR, Lubahn DB, Wilson EM, Joseph DR, French FS, Migeon CJ. 1988 Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci USA. 85:8151-8155.
24. 3-resistant rickets in three families. Proc Natl Acad Sci USA. 86:9783-9787.
25. George FW, Wilson JD. 1988 Sex determination and differentiation. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 3-26.